Diabetes, obesity, and cardiovascular disease are among a group of devastating, common disorders of metabolism that afflict millions of people. The Broad's Metabolic Disease Initiative strives to advance knowledge of these illnesses and accelerate the development of new therapies and disease-prevention strategies.
Scientists in the Metabolic Disease Initiative share ideas and launch collaborative projects to tackle key challenges. The program works closely with scientists in the Proteomics Platform. In addition, it collaborates with many other labs in the Harvard-MIT community and elsewhere.
